Evaluation of Pepsinogen A and Gastrin-17 as Markers of Gastric Cancer and High-Risk Pathologic Conditions

References

• Laufer I, Mullens J E., Hamilton J. The diagnostic accuracy of barium studies of the stomach and duodenum–correlation with endoscopy. Radiology 1975; 115: 569–73
   PubMed Web of Science ®Google Scholar
• Holdstock G, Bruce S. Endoscopy and gastric cancer. Gut 1981; 22: 673–6
   PubMed Web of Science ®Google Scholar
• Allum W H., Powell D J., McConkey C C., Fielding J WL. Gastric cancer: a 25 year review. Br J Surg 1989; 76: 535–40
   PubMedGoogle Scholar
• Hisamichi S, Sugawara N. Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol 1984; 14: 211–23
   PubMedGoogle Scholar
• Hallissey M, Jewkes A, Allum W, Ellis D, Fielding J. Early detection of gastric cancer. Br Med J 1990; 301: 513–5
   PubMed Web of Science ®Google Scholar
• Williams G T., Rogers K. Elevated gastric juice enzymes–a marker for increased gastric cancer risk?. Clin Oncol 1984; 10: 319–23
   Google Scholar
• Hakkinen I PT, Heinonen R, Inberg M V., Jarvi O H., Vaajalhti P, Viikaria S. Clinicopathological study of gastric cancers and precancerous states detected by fetal sulfoglycoprotein antigen screening. Can Res 1979; 40: 4308–12
   Google Scholar
• Samloff I M. Cellular localisation of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971; 61: 185–8
   PubMed Web of Science ®Google Scholar
• Stemmermann G N., Samloff I M., Nomura A, Walsh J H. Serum pepsinogen I and gastrin in relation to extent and location of intestinal metaplasia in the surgically resected stomach. Dig Dis Sci 1980; 25: 680–7
   PubMedGoogle Scholar
• Varis K, Samloff I M., Ihämaki T, Siurala M. An appraisal of test for severe atrophic gastritis in relatives of patients with pernicious anaemia. Dig Dis Sci 1979; 24: 187–91
   PubMed Web of Science ®Google Scholar
• Varis K, Isokoski M. Screening of type A gastritis. Ann Clin Res 1981; 13: 133–8
   PubMedGoogle Scholar
• Westerveld B D., Pals G, Défize J, et al. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach. Pepsinogen in man: clinical and genetic advances. 173rd ed. Alan R Liss, New York 1985; 201–12, Progress in Clinical and Biological Research; Vol 173
   Google Scholar
• Muir C, Waterhouse J AH, Mark T, Powell D J., Whelan S. Cancer incidence in five continents. IARC Scientific Publications, Lyon 1987; Vol. V
   Google Scholar
• Hirayama T. Methods and results (cost effectiveness) of gastric cancer screening. Gastric cancer, J WL Fielding, C E. Newman, C HJ Ford, B G. Jones. Pergamon Press, Oxford 1981, Advances in the Biosciences; Vol 32
   Google Scholar
• Lundh G, Burn J I., Kolig G, et al. A co-operative international study of gastric cancer. Ann R Coll Surg Engl 1974; 54: 219–28
   PubMedGoogle Scholar
• Eliis D J., Kingston R D., Brookes V S., Waterhouse J AH. Gastric carcinoma and previous peptic ulceration. Br J Surg 1979; 66: 117–9
   Google Scholar
• Rogers K, Roberts G M., Williams G T. Gastric juice enzymes– an aid to the diagnosis of gastric cancer. Lancet 1981; 1: 1124–5
   PubMed Web of Science ®Google Scholar
• Hakkinen I PT. Application of serum and gastric juice tumour markers to early diagnosis and screening of gastric cancer. Gastric cancer, J WL Fielding, C E. Newman, C HJ Ford, B G. Jones. Pergamon Press, Oxford 1981; 85–94, Advances in the Biosciences; Vol 32
   Google Scholar
• Finch P, Ryan F P., Rogers K, Holt S. Estimation of lactic dehydrogenase and beta-glucuronidase in gastric juice as a routine screening test for gastric cancer. Gut 1984; 25: A1187
   Google Scholar
• Waldum H L., Burhol P G., Straime B K. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin output before and after subcutaneous injection of pentagastrin. Scand J Gastroenterol 1978; 13: 943–6
   PubMed Web of Science ®Google Scholar
• Plebani M, Di Mario F, Vianello F, et al. Pepsinogen group I radioimmunoassay and total serum colorimetric determination: a comparative study in normal subjects and peptic ulcer patients. Clin Biochem 1983; 16: 20–2
   PubMedGoogle Scholar
• Peyre S, Di Napoli A, Pelissero A, Sategna-Guidette C. Diagnostic usefulness of serum group I pepsinogen determination. Gastroenterol Clin Biol 1983; 7: 793–8
   Google Scholar
• Stemmermann G N., Ishidate T, Samloff I M., et al. Intestinal metaplasia of the stomach in Hawaii and Japan: a study of its relations to serum pepsinogen I, serum gastrin and parietal cell antibody. Dig Dis 1978; 23: 815–20
   Google Scholar
• Itoh T, Tatsuta M, Tamura H, Yamamura H, Iwanaga T. Studies on serum gastrin of the patients with gastric cancer. Am J Gastroenterol 1977; 68: 56–63
   Google Scholar
• Lewin K J., Dowling F, Wright J P., Taylor K B. Gastric morphology and serum gastrin levels in pernicious anaemia. Gut 1976; 17: 551–60
   PubMedGoogle Scholar
• Strickland R G., Bhathal R S., Korman M G., Hansky J. Serum gastrin and the antral mucosa in atrophic gastritis. Br Med J 1971; 4: 451–3
   PubMed Web of Science ®Google Scholar
• Westerveld B D., Pals G, Lamers C BHW, et al. Clinical significance of pepsinogen A isoenzymes, serum pepsinogen A and C levels and serum gastrin levels. Cancer 1987; 59: 952–8
   PubMed Web of Science ®Google Scholar
• Huang S C., Miki K, Furihata C, Ichinose M, Shimizu A, Oka H. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies–with data on peptic ulcer and gastric cancer. Clin Chim Acta 1988; 175: 37–50
   PubMed Web of Science ®Google Scholar
• Hansky J. Gastrins and gastrinomas. Postgrad Med J 1984; 60: 767–72
   Google Scholar